Biomedical subjects

L D Devoe

Publications and source records attributed to L D Devoe.

At least 37 records · Page 2Linked to original sources

PubMed1999

Cannabinoid receptors and their role in the regulation of the serotonin transporter in human placenta.

OBJECTIVE: We sought to investigate the expression of cannabinoid receptors in human placenta and BeWo choriocarcinoma cells and study their role in the regulation of the serotonin transporter. STUDY DESIGN: Expression of the 2 types of cannabinoid receptors (CB1 and CB2) in human placenta and BeWo cells was investigated by reverse transcriptase-polymerase chain reaction and Northern blot analysis. The involvement of the receptors in the regulation of the serotonin transporter expression was studied by using a cannabinoid receptor agonist (WIN 55212-2). BeWo cells were treated with the agonist in the presence or absence of forskolin, and the serotonin transporter activity was measured by assessing paroxetine-sensitive serotonin transport. Serotonin transporter density in cell membranes was monitored by measuring paroxetine-sensitive binding of RTI-55, a specific high-affinity ligand for the transporter. Agonist-induced changes in intracellular levels of cyclic adenosine monophosphate were also monitored. RESULTS: Reverse transcriptase-polymerase chain reaction and Northern blot analysis demonstrated unequivocally that human placenta and BeWo cells express both types of cannabinoid receptors. Treatment of BeWo cells with the receptor agonist blocked the activity of the constitutive, as well as the forskolin-induced, serotonin transporter without affecting the serotonin transporter density. This effect is not mediated by alterations in intracellular cyclic adenosine monophosphate levels. CONCLUSION: The results show that cannabinoid receptors are expressed in human placenta and BeWo cells and play a role in the regulation of the serotonin transporter activity. Human placenta is therefore a direct target for cannabinoids, and marijuana use during pregnancy is likely to affect the placental clearance of serotonin through the serotonin transporter.

Benzoxazines↗

PubMed1999

Detection of growth-restricted fetuses in preeclampsia: a case-control study.

OBJECTIVE: To determine the diagnostic accuracy of detecting growth-restricted fetuses in women with and without preeclampsia. METHODS: Over 2 years, parturients with reliable gestational ages, preeclampsia, and sonographic estimates of birth weights were matched (1:1) for gestational age with women without preeclampsia. Paired and unpaired t tests were used; P < .05 was significant. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. RESULTS: Two hundred eighty-seven preeclamptic women were identified and matched. In each group, mean (+/- standard deviation [SD]) gestational age was 34.9 +/- 4.2 weeks, and 166 (57.8%) infants were born preterm. Fetal growth restriction (FGR) was significantly more common among women with preeclampsia (14.9%) than among controls (5.6%; OR 2.98, 95% CI 1.64, 5.44). The percentage of sonographic estimates within 10% of actual birth weight (57.5% versus 53.6%) was similar in the two groups (OR 1.16; 95% CI 0.84,1.62). Compared with normal growth, the mean (+/- SD) standardized absolute error was significantly higher among those with FGR regardless of group (preeclampsia 109 +/- 100 versus 158 +/- 152 g/kg; P = .009; control 117 +/- 103 versus 233 +/- 206 g/kg; P < .001). Fetal growth restriction was detected more commonly among preeclamptic women than among controls (11.6% versus 0%; OR 4.74 95% CI 0.25, 90.31). The sensitivity and positive predictive value of FGR detection were 10% and 50%, respectively, among women with preeclampsia and 0% each among controls. CONCLUSION: Although FGR was detected more frequently in fetuses of women with preeclampsia than in those of controls, the ability to predict it with sonography remained poor.

Adult↗

PubMed1999

Nonstress testing and contraction stress testing.

Antepartum fetal heart rate (FHR) testing, including the nonstress test and contraction stress test, has evolved in clinical usage over the past 3 decades. Although the nonstress test has become a standard of care in high-risk pregnancy, it has been modified by the use of fetal stimulation (vibroacoustic stimulation) and the addition of automated fetal movement recording (actocardiotocography). In all of its formats, antepartum FHR testing has been associated with reduction of preventable fetal loss. More recently, there have been attempts to improve test efficacy by computer-enhanced approaches.

Cardiotocography↗

PubMed1999

Risk factors associated with blood transfusion in ectopic pregnancy.

OBJECTIVE: To determine the risk factors associated with blood transfusion in ectopic pregnancy. STUDY DESIGN: A retrospective chart review of the presentation and hospital course of ectopic pregnancies managed over five years at two hospitals was undertaken. Thirty-two variables, including demographics, presenting signs and symptoms, and intraoperative findings, were examined with univariate and multivariate logistic modeling. RESULTS: Among 185 patients with histologically confirmed ectopics who were managed surgically, 8.6% (16 women) required transfusion. Multivariate analysis of risk factors for blood transfusion demonstrated a statistically significant association with (1) initial hemoglobin < 10 g/dL (odds ratio [OR] 38.8, 95% confidence interval [CI] 6.0-356.8); (2) human chorionic gonadotropin levels > or = 6,500 mIU (OR 18.1, 95% CI 3.6-158.1); and (3) abnormal bleeding on presentation (OR 0.08, 95% CI 0.007-0.42). The presence of two of these factors had a sensitivity of 82% (95% CI 48-98%) and a positive predictive value of 33% (95% CI 16-54%). No case had all three factors. CONCLUSION: This study was, to our knowledge, the first regression analysis of risk factors for transfusion associated with ectopic pregnancy. It demonstrated that initial hemoglobin and human chorionic gonadotropin levels as well as abnormal bleeding on presentation are independent risk factors for blood transfusion in ectopic pregnancy.

Adult↗

PubMed1998

Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate.

Previous studies have shown that a Na+-dependent transport system is responsible for the transplacental transfer of the vitamins pantothenate and biotin and the essential metabolite lipoate. We now report the isolation of a rat placental cDNA encoding a transport protein responsible for this function. The cloned cDNA, when expressed in HeLa cells, induces Na+-dependent pantothenate and biotin transport activities. The transporter is specific for pantothenate, biotin, and lipoate. The Michaelis-Menten constant (Kt) for the transport of pantothenate and biotin in cDNA-transfected cells is 4.9 +/- 1.1 and 15.1 +/- 1.2 microM, respectively. The transport of both vitamins in cDNA-transfected cells is inhibited by lipoate with an inhibition constant (Ki) of approximately 5 microM. The nucleotide sequence of the cDNA (sodium-dependent multivitamin transporter (SMVT)) predicts a protein of 68.6 kDa with 634 amino acids and 12 potential transmembrane domains. Protein data base search indicates significant sequence similarity between SMVT and known members of the Na+-dependent glucose transporter family. Northern blot analysis shows that SMVT transcripts are present in all of the tissues that were tested. The size of the principal transcript is 3.2 kilobases. SMVT represents the first Na+-dependent vitamin transporter to be cloned from a mammalian tissue.

Amino Acid Sequence↗

PubMed1998

Ultrasonographic estimate of birth weight at 24 to 34 weeks: a multicenter study.

OBJECTIVE: The study was intended to compare the accuracies of ultrasonographic estimates of birth weights among infants born between 24 and 34 weeks' gestation at 3 tertiary centers. STUDY DESIGN: In this retrospective study subjects were matched for gestational age (1:1); all underwent ultrasonographic examination within 2 weeks of delivery. The estimates of birth weight were obtained according to 26 published regression equations and their accuracies were assessed with the mean standardized absolute error. For each center the equation with the lowest error was selected to generate (1) receiver-operating characteristic curves for an estimate to identify actual weight < 1500 g and (2) prediction limit calculations to determine the estimate that ensures at 70% confidence a birth weight > 1500 g. RESULTS: One hundred seventy-one cases were analyzed at each center. Comparison of the 26 mean standardized errors at each center indicated that (1) the range was rather wide (eg, 89 +/- 87 to 365 +/- 313 g/kg) and (2) 73% (19/26) of the equations had significantly (P < .05) different accuracies. Receiver-operator characteristic curves show that fetal weight estimates of > or = 1600 g at 2 centers and > or = 1700 g at the third center are required to predict actual birth weight < 1500 g. Prediction limit calculation suggests that different fetal weight estimates (> 1600 g at center 1, > 1900 g for the center II, and > 1800 g at center III) are needed to predict actual weight > 1500 g with a 70% accuracy. CONCLUSIONS: Ultrasonographic estimates of weight for preterm infants, as obtained from 26 equations, are characterized by a rather wide range of accuracy; for most of the equations the accuracies of estimates differ markedly among centers.

Birth Weight↗

PubMed1998

Limitations of clinical and sonographic estimates of birth weight: experience with 1034 parturients.

OBJECTIVE: To compare the accuracy of clinical and sonographic estimates of fetal weight made throughout the third trimester of pregnancy. METHODS: Patients in early labor had fetal weight estimated by two approaches: 1) clinical evaluation and palpation followed by 2) sonographic mensuration of fetal biparietal diameter, abdominal circumference, and femur length applied to Hadlock's formula. The accuracy of these two methods of estimating fetal weight was compared using Student t test, Wilcoxon test, and chi2 tests. P < .05 was considered significant. Prediction limits (50th, 90th, and 95th percentiles) were calculated for both techniques by obtaining the range of actual weights associated for a particular estimated fetal weight (EFW). RESULTS: We enrolled 1034 parturients whose clinical EFWs yielded significantly higher mean (+/- standard deviation) simple error (48.2 +/- 411 g) and standardized absolute error (130 +/- 122 g/kg) than were obtained by use of sonographic formulas for EFW (-6.6 +/- 381 g and 104 +/- 89 g/kg, respectively). When the population was partitioned by gestational age, we found that sonographic EFW was more accurate than clinical EFW in preterm (n = 373) but not in term (n = 460) or post-term (n = 201) pregnancies. Prediction limits indicate that for a given EFW, for example, 800 g, the 90% ranges of actual weight based on clinical and sonographic EFW are 566-1829 g and 469-1667 g, respectively. CONCLUSION: The apparent superiority of sonographic EFW over clinical EFW applies principally to preterm pregnancies. The prediction limitation calculation suggests that either method, for any particular estimate between 500 and 4500 g, has limited value in the estimation of actual birth weight, because this outcome is highly variable and frequently lies outside of the useful bandwidth (+/- 10%) for prospective management.

Adult↗

PubMed1998

Intrapartum amniotic fluid index: a poor predictor of abnormal fetal size.

OBJECTIVE: Using receiver-operating characteristic (ROC) curves, we tried to determine the diagnostic threshold of amniotic fluid index (AFI) that will identify abnormal fetal size (birth weights under 2500 g or at least 4000 g) at 37 weeks or beyond. METHODS: We analyzed prospectively over 2 years all parturients with intact membranes and known AFI in early labor. Patients with the following conditions were excluded: pregestational or gestational diabetes, known anomalies, and preterm labor. Two ROC curves were constructed, and the areas (+/- standard error of the mean [SE]) under the curves were calculated. P < .05 was considered significant. RESULTS: Of the 1038 subjects meeting study criteria, 3.6% and 11.5% gave birth to infants who were small for gestational age (SGA) or macrosomic, respectively. Overall, 28.7% had oligohydramnios (AFI at most 5.0 cm) and 3.6% had hydramnios (AFI at least 24.0 cm). Small for gestational age was more common in patients with AFI at most 5.0 cm (6.4%) than in those with adequate fluid (AFI 5.1-23.9; 2.5%), or hydramnios (2.7%; P = .012). Macrosomic newborns were less likely to be born to women with oligohydramnios (7.7%) than to those with adequate amniotic fluid (13.1%) or hydramnios (13.5%). Areas under ROC curves are not significantly different from the area under the nondiagnostic line, indicating that AFI (0-34 cm) cannot differentiate between newborns under 2500 g and at or over 2500 g or under 4000 and at or more 4000 g. CONCLUSION: Intraparterium AFI appears to be a poor screening test to identify risk for delivery of SGA or macrosomic fetus.

Adult↗

PubMed1998

Bishop score: a poor diagnostic test to predict failed induction versus vaginal delivery.

BACKGROUND: We evaluated the accuracy of the Bishop score in predicting the likelihood of successful labor induction (entry into active phase) in nulliparous and multiparous women. METHODS: During an index year, all patients having induction of labor and a preinduction Bishop score were included in a standard protocol for cervical ripening and use of oxytocin. Receiver-operating characteristic (ROC) curves were constructed for Bishop scores (0 to 11) to predict abdominal delivery for failed induction (final cervical dilation <4 cm) versus vaginal delivery. RESULTS: Parturients who had vaginal delivery (n = 253) and those in whom attempted induction failed (n = 38) did not differ significantly with respect to maternal demographics, length of gestation, Bishop score and its distribution, and infant birth weight. The area under the ROC curve did not differ significantly from the area under the nondiagnostic line. CONCLUSION: The Bishop score appears to be a poor predictor of the outcome of labor induction.

Adult↗

PubMed1998

Unengaged vertex in nulliparous women in active labor. A risk factor for cesarean delivery.

OBJECTIVE: To compare the route of delivery among nulliparous parturients with and without an engaged vertex in the early, active phase of labor. METHODS: Prospectively, the position of the fetal head was ascertained among nulliparous women at 37 weeks' gestation or more in early, active labor (cervical dilation > or = 4 cm with adequate contractions). Sixteen variables, including maternal demographics, obstetric complications and intrapartum course, were examined using chi 2 and logistic regression analysis. RESULTS: Among the 77 patients, 33 (42.8%) had an unengaged vertex and 44 (57.2%) had an engaged vertex in active labor. Of the 22 cesarean deliveries for arrest disorder, 2 were in the engaged and 20 in the unengaged group (P < .001). The mean birth weight was similar among those who had vaginal (3,211 +/- 416 g) and cesarean delivery (3,400 +/- 489 g, P = .08). Univariate analysis indicated that chorioamnionitis (relative risk [RR] 2.6, 95% confidence interval [CI] 1.4-4.9) and unengaged vertex (RR 13.3, CI 3.3-53.0) were associated with cesarean delivery for arrest disorders. When entered into a multiple logistic model, only unengagement was a risk factor for cesarean delivery. The following were not associated with cesarean delivery: maternal demographics, gestational age, estimate of fetal weight, presence or absence of meconium, preeclampsia, diabetes mellitus, private obstetric care or use of epidural anesthesia. CONCLUSION: Among nulliparous parturients, an unengaged vertex is a significant risk factor for cesarean delivery for arrest disorders.

Adolescent↗

PubMed1997

Ultrasonographic assessment of amniotic fluid does not reflect actual amniotic fluid volume.

OBJECTIVE: Our objective was to compare the ability of two methods of amniotic fluid assessment (two-diameter amniotic fluid pocket versus the amniotic fluid index) to predict oligohydramnios (actual amniotic fluid volume < 500 ml) or polyhydramnios (actual amniotic fluid volume > 1500 ml). STUDY DESIGN: The amniotic fluid index and the two-diameter amniotic fluid pocket were assessed before amniocentesis and determination of amniotic fluid volume with the dye (aminohippurate sodium)-dilution technique. To assess the detection of either oligohydramnios or polyhydramnios, the areas under the receiver-operator characteristic curves (+/-SE) were estimated by the point-to-point trapezoidal method of integration. Prediction limits were calculated by regression analysis of amniotic fluid index or two-diameter amniotic fluid pocket versus actual amniotic fluid volume and determination of 95th percentile ranges for amniotic fluid volume. RESULTS: We studied 144 patients with a mean (+/-SD) gestational age of 31.7 +/- 5.5 weeks; mean (+/-SD) amniotic fluid index and two-diameter amniotic fluid pocket were 12.6 +/- 6.1 cm and 21.2 +/- 18.4 cm2, respectively. Mean (+/-SD) actual amniotic fluid volume was 722 +/- 735 ml (range 101 to 4318 ml). The areas under the four receiver-operator characteristic curves were not significantly different from the nondiagnostic line (p < 0.05). Regression slopes (r values) for amniotic fluid index and two-diameter amniotic fluid pocket versus actual amniotic fluid volume were 0.34 and 0.23, respectively. Calculation of the prediction limit for 95% confidence that oligohydramnios is absent requires that the amniotic fluid index be 30 cm and the two-dimension amniotic fluid pocket be 90 cm2, both thresholds of which are currently considered to represent clinical polyhdramnios. CONCLUSIONS: Both amniotic fluid index and two-dimension amniotic fluid pocket appear to be inaccurate predictors of actual oligohydramnios or polyhydramnios when compared with dye-dilution calculations of actual amniotic fluid volume.

Adult↗

PubMed1997

Intrapartum oligohydramnios does not predict adverse peripartum outcome among high-risk parturients.

OBJECTIVE: Oligohydramnios can be defined by an amniotic fluid index < 5th percentile for gestational age or an amniotic fluid index < or = 5.0 cm regardless of gestational age. The purpose of this prospective study was to determine whether oligohydramnios by either definition predicts accurately, in a high-risk population, the risks for cesarean section for fetal distress, Apgar score < 7 at 5 minutes, and neonatal acidosis. STUDY DESIGN: An amniotic fluid index was obtained in 490 consecutive parturients with medical or obstetric complications and a reliable gestational age. After each delivery, an umbilical arterial blood gas analysis was obtained. Both measures of amniotic fluid index were rated as screening tests with use of sensitivity, specificity, predictive values, and receiver-operator characteristic curves. RESULTS: The incidences of cesarean section for fetal distress and umbilical arterial pH < 7.00 were 14% and 1.8%, respectively. The 70 neonates delivered by cesarean section for distress, compared with the 420 without, had a significantly higher incidence of pH < 7.00 (8.5% vs 0.7%, p = 0.0004, relative risk 5.0, 95% confidence interval 2.9 to 8.4). Sensitivity and positive predictive values of an amniotic fluid index < 5th percentile for gestational age to predict pH < 7.00 were 0.8% and 22%, respectively, and for an amniotic fluid index < or = 5.0 cm, 0.5% and 11%, respectively. Receiver-operator characteristic curves indicate that an amniotic fluid index between 0 and 20 cm cannot predict accurately which parturients will have cesarean sections for distress or be delivered of a newborn with a low Apgar score at 5 minutes or a pH < 7.10. CONCLUSION: Both criteria for oligohydramnios are poor predictors of adverse outcome for high-risk intrapartum patients.

Adolescent↗

PubMed1997

Sonographic examination does not predict twin growth discordance accurately.

OBJECTIVE: To assess the accuracy of estimating birth weight among twins with discordancy (intra-pair difference in actual birth weight of more than 25%) and to determine the relative accuracy of an intra-pair difference in abdominal circumference (delta AC) of 20 mm or more or in estimated fetal weight (delta EFW) of 25% or more for the identification of discordant growth in twins. METHODS: Over a 6-year period, we identified all non-anomalous twin pairs with gestational ages greater than 23 weeks and sonographic examinations within 3 weeks of birth. Ultrasonographic biometry of both twins included AC, head circumference, and femur length; these indices were used to estimate fetal weight by Hadlock's formula. Likelihood ratios, receiver-operating characteristic curves, and prediction limits were applied to assess the accuracy of the two diagnostic methods to predict an abnormal outcome. RESULTS: A total of 242 twin pairs were studied. The mean gestational age among the 21 twins with abnormal growth (30.6 +/- 4.6 weeks) was significantly less than among the 221 twins with normal growth (33.2 +/- 4.0 weeks) (P < .005). The biometric measurements of fetal parts, sonographic estimate of fetal weight, and actual birth weight for both fetuses were significantly less for discordant twin pairs (P < .05). The accuracy of predicting birth weight, as determined by mean error and percentage of the estimate within 10% of the actual weight, was similar between the groups. Receiver-operating characteristic curves showed that both diagnostic tests yielded areas under the two curves not significantly different from the area under the nondiagnostic line (P > .05). Most important, prediction limit calculations indicated that a 90% certainty that the actual birth weight discordance was at least 25% was achievable only if delta AC was 172 mm or greater or delta EFW was 112% or more. CONCLUSION: The most popular current methods (difference in AC or EFW) for predicting discordant growth in twin gestations have limited accuracy when held to a standard for discordance that requires a birth weight difference of at least 25%.

Birth Weight↗

PubMed1997

Managed care in obstetrics.

Managed care has marched relentlessly through all fields of obstetric care: individual and group practices, proprietary hospitals and academic medical centers, and public health systems. Emphasis on cost containment while preserving high quality has driven the redesign of healthcare delivery. A number of models for providing effective and less expensive obstetric care are now being examined in the USA and abroad. Increased market penetration by managed care will also exert profound and possibly harmful effects on traditional academic teaching institutions. These organizations must adapt to this new environment or face the erosion of physician support and training bases. Ultimately, significant moral and ethical dilemmas will arise when patients' best interests for care are being continually brought into conflict with the physician's need to earn a living.

Community Health Planning↗

PubMed1996

Computerized fetal heart rate analysis and neural networks in antepartum fetal surveillance.

The use of computers for analysis of fetal heart rate has developed rapidly, enabling reproducible, objective analysis of fetal heart rate patterns. The problems of observer differences in visual assessment of fetal heart rate, and the continuum of antepartum and intrapartum fetal condition can be clarified through the use of such approaches. Computerized fetal heart rate analysis presents opportunities to perform precise evaluations of the effects of environmental conditions, medications, and disease states on fetal heart rate parameters.

Computer Communication Networks↗

PubMed1995

Neural network prediction of nonstress test results: how often should we perform nonstress tests?

OBJECTIVE: Our purpose was to predict outcomes and optimal intervals for nonstress tests of term gravid women with neural networks. STUDY DESIGN: We studied 100 normal term patients whose 30-minute nonstress tests, performed on 5 consecutive days, were computer analyzed for the following elements: fetal heart rate baseline, variability, signal loss, accelerations (> 15 beats/min), and decelerations. The training set used 65 patients; the testing, 35 patients. Nonstress test data (days 1 to 4) were inputs; day 5 data were training patterns. Networks for each nonstress test element used Brainmaker Macintosh 1.0 (California Scientific Software, Nevada City, Calif.) trained to 0.12 tolerance. Actual fetal heart rate elements and their daily differences were compared with predictions by the networks and multiple regressions. RESULTS: There was little difference between networks using daily or alternate-day inputs for predicting test performance on day 5; networks using test intervals > 2 days could not be trained to tolerance. Long-term fetal heart rate variation was the nonstress test element best predicted. Daily differences networks provided better prediction of all day 5 data than did actual daily values networks or multiple regression formulas. CONCLUSIONS: Baseline long-term fetal heart rate variability seems to be the most predictable fetal heart rate element over time and should merit more consideration in overall fetal testing. Fetal heart rate elements are not easily predicted by any method for intervals longer than 2 days. Using longer test intervals might run a greater risk for unanticipated changes in nonstress test outcomes, even when fetal condition is normal.

Female↗

PubMed1995

Antenatal assessment of twin gestation.

We have identified that twin gestation presents considerable risks to the well-being of both infants that can be traced to either related maternal or intrinsic fetoplacental factors. A protocol for the assessment of twin gestation is established, beginning with a basis in ultrasound identification of twinning and correct gestational dating. Because most hazards for twins are related to abnormal growth, discrepant growth between twins, and abnormalities of placentation, the approach to assessing well-being requires good serial biometry of twins. This critical review addresses the individual and combined application of standard tests used for evaluation of intrauterine health in single pregnancies: (1) ultrasound fetal growth curves; (2) Doppler velocimetry of the umbilical artery; (3) nonstress tests; (4) amniotic fluid assessment and (5) biophysical profile testing. The best current evidence suggests that there are clear deficiencies in the basis for growth nomograms for twin gestations, and with the exception of femur length, most individual anatomic measurements start to deviate from singleton standards between 21 and 30 weeks' gestation. Regardless of formulae used, estimated fetal weight provides the best discriminator for discordant growth. Dynamic assessment of fetal well-being is best provided by a combination of Doppler velocimetry and nonstress testing. Semiquantitative amniotic fluid assessment, other than establishing pathological conditions (eg, twin transfusion syndrome), is problematic and difficult to reproduce. Inadequate data exist to establish the value of the biophysical profile in twins. Given the limitations of present knowledge, serial assessment of twins beginning in the midtrimester with ultrasound observation, and adding combinations of Doppler velocimetry and nonstress testing in the third trimester, seems to represent the most reasonable current clinical approach to twin well-being.

Diseases in Twins↗

PubMed1995

Effect of magnesium on fetal heart rate variability using computer analysis.

We studied 16 women, at 32 weeks' or more gestation who required magnesium sulfate (MgSO4) therapy for preterm labor or preeclampsia. A 60-minute Doppler fetal heart rate (FHR) tracing, analyzed by the Oxford Sonicaid System 8000, was obtained for 1 hour before and 2 hours after each patient received intravenous MgSO4 therapy. Maternal serum Mg2+ levels were obtained at the second monitoring session. Matched paired measures of FHR parameters were compared with the Student's t test. After MgSO4 administration, we noted significant falls in long-term variability, short-term variability, and total acceleration (more than 10 beats/min) counts. Reduced short-term and overall variability occurred in all cases with maternal serum Mg2+ levels more than 4.6 mg/dL. Therapeutic maternal serum Mg2+ levels are linked with decreases in long-term and short-term FHR variability and acceleration counts. These findings should be considered when evaluating resting FHR baseline of patients thus treated.

Adult↗